Technical Analysis for AYTU - Aytu BioScience, Inc.

Grade Last Price % Change Price Change
grade C 1.89 1.07% 0.02
AYTU closed up 1.07 percent on Friday, May 24, 2019, on 12 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical AYTU trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 50 DMA Bearish 1.07%
MACD Bearish Centerline Cross Bearish 1.07%
180 Bearish Setup Bearish Swing Setup 1.07%
200 DMA Support Bullish 1.07%
Wide Bands Range Expansion 1.07%
Oversold Stochastic Weakness 1.07%

Older signals for AYTU ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Aytu BioScience, Inc. is a commercial-stage healthcare company focused on acquiring, developing and commercializing products in the field of urology. The Company focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. The Company markets ProstaScint (capromab pendetide), a radio imaging agent indicated to detect the prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. The Company's pipeline includes MiOXSYS, an in vitro diagnostic device. MiOXSYS system is a point-of-care semen analysis system, used for diagnosis and management of male infertility. The Company holds the United States rights to Natesto (testosterone), a formulation of testosterone delivered through a nasal gel. Natesto is used for the treatment of hypogonadism (low testosterone) in men. The Company, through its wholly-owned subsidiary Nuelle, Inc., is focused on women’s sexual wellbeing and intimacy.
Healthcare Organ Systems Prostate Cancer Alcohols Hormones Ketones Company's Pipeline Urinary Tract Infections Androstanes Estrogens Male Infertility Testosterone
Is AYTU a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.38
52 Week Low 0.68
Average Volume 733,911
200-Day Moving Average 1.8243
50-Day Moving Average 1.939
20-Day Moving Average 2.0721
10-Day Moving Average 1.975
Average True Range 0.1698
ADX 32.41
+DI 23.4401
-DI 15.6772
Chandelier Exit (Long, 3 ATRs ) 2.1006
Chandelier Exit (Short, 3 ATRs ) 2.2794
Upper Bollinger Band 2.3945
Lower Bollinger Band 1.7497
Percent B (%b) 0.22
BandWidth 31.118189
MACD Line -0.0119
MACD Signal Line 0.0334
MACD Histogram -0.0453
Fundamentals Value
Market Cap 7.6 Million
Num Shares 4.02 Million
EPS -48.30
Price-to-Earnings (P/E) Ratio -0.04
Price-to-Sales 4.58
Price-to-Book 0.76
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.07
Resistance 3 (R3) 2.08 2.02 2.04
Resistance 2 (R2) 2.02 1.98 2.02 2.03
Resistance 1 (R1) 1.96 1.95 1.93 1.95 2.02
Pivot Point 1.90 1.90 1.89 1.90 1.90
Support 1 (S1) 1.84 1.86 1.81 1.83 1.76
Support 2 (S2) 1.78 1.83 1.78 1.75
Support 3 (S3) 1.72 1.78 1.74
Support 4 (S4) 1.71